Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Healt
This clinical trial compares the impact of the Smart Symptom Tracking ALEX application (app) to standard symptom-tracking practices in tracking and monitoring gastrointestinal (GI) symptoms in young adults. Rates of early-onset colorectal cancer are rising sharply and it is projected to become the leading cause of canc
| Condition(s) | Colorectal Carcinoma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This clinical trial compares the impact of the Smart Symptom Tracking ALEX application (app) to standard symptom-tracking practices in tracking and monitoring gastrointestinal (GI) symptoms in young adults. Rates of early-onset colorectal cancer are rising sharply and it is projected to become the leading cause of cancer-related death in young adults. Despite this, adults under 45 still face barriers to diagnosis, including access to screening, unclear guidance on the impact of GI symptoms and dismissal of symptoms by healthcare providers. Current screening guidelines lack guidance on monitoring early symptoms in younger adults. The Smart Symptom Tracking ALEX tool is a digital platform that uses artificial intelligence to provide prompts for symptoms, coaching, reminders and education. St |
| Who can participate | Inclusion Criteria: * Ages 18-44 years * Concerned about their GI health * Able to speak and read English * Willing to complete a four-week symptom tracking protocol Exclusion Criteria: * Unable to understand the informed consent or comply with protocol requirements |
| Ages | 18 Years to 44 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Mayo Clinic |
| Locations | Jacksonville, Florida, United States |
| Start date | 2026-04-20 |
| NCT ID | NCT07618273 |
| Official listing | https://clinicaltrials.gov/study/NCT07618273 |